These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy]. Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133 [TBL] [Abstract][Full Text] [Related]
5. [The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm]. Nishizawa Y Nihon Rinsho; 1993 Dec; 51 Suppl():389-96. PubMed ID: 8121018 [No Abstract] [Full Text] [Related]
6. [Long-term anticoagulant therapy for transient ischemic attack and cerebral infarct with minor symptoms]. Müller R; Olsson JE Lakartidningen; 1977 Nov; 74(45):3973-8. PubMed ID: 926938 [No Abstract] [Full Text] [Related]
7. Subarachnoid fibrinolytic treatment for the prevention of cerebral vasospasm. Findlay JM Semin Neurol; 1991 Dec; 11(4):400-10. PubMed ID: 1811295 [No Abstract] [Full Text] [Related]
9. [3GS prevention and therapy of transient cerebral ischemic attacks in the aged]. Mancini M; Dall'Asta D; Maini C; Cucinotta D G Clin Med; 1983; 64(1-2):51-65. PubMed ID: 6345252 [No Abstract] [Full Text] [Related]
10. [Treatment of vasospasm with beta-mimetics: study of cerebral blood flow]. Dematons C; Goldstein A; Muzard O; George B; Luft A; Raggueneau JL Agressologie; 1984 Jun; 25(7):823-6. PubMed ID: 6148901 [No Abstract] [Full Text] [Related]